Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EZM0414 is a potent, selective, orally bioavailable inhibitor of SETD2 with IC50 of 18 nM in SETD2 biochemical assay and IC50 of 34 nM in a cellular assay. EZM0414 can be used for the research of relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 279.00 | |
5 mg | In stock | $ 688.00 | |
10 mg | In stock | $ 978.00 | |
25 mg | In stock | $ 1,460.00 | |
50 mg | In stock | $ 1,960.00 | |
100 mg | In stock | $ 2,650.00 |
Description | EZM0414 is a potent, selective, orally bioavailable inhibitor of SETD2 with IC50 of 18 nM in SETD2 biochemical assay and IC50 of 34 nM in a cellular assay. EZM0414 can be used for the research of relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma [1]. |
Molecular Weight | 400.49 |
Formula | C22H29FN4O2 |
CAS No. | 2411748-50-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 115 mg/mL (287.15 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EZM0414 2411748-50-8 Chromatin/Epigenetic Histone Methyltransferase EZM 0414 EZM-0414 inhibitor inhibit